Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting

J Neurol. 2025 Jun 4;272(6):444. doi: 10.1007/s00415-025-13107-y.

Simona Malucchi¹, Cecilia Irene Bava², Paola Valentino^{2

3}, Serena Martire^{2

4}, Marianna Lo Re⁵, Antonio Bertolotto^{2

6}, Alessia Di Sapio⁵

¹ Department of Neurology and CRESM, University Hospital San Luigi Gonzaga, Regione Gonzole 10, 10043, Orbassano, Italy. simona.malucchi@gmail.com.
² NICO-Neuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy.
³ Department of Clinical and Biological Science, University of Turin, Turin, Italy.
⁴ Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
⁵ Department of Neurology and CRESM, University Hospital San Luigi Gonzaga, Regione Gonzole 10, 10043, Orbassano, Italy.
⁶ Koelliker Hospital, C.so Galileo Ferraris, 247/255, 10134, Turin, Italy.

No abstract available

Publication types